Ultrasonographic alterations associated with the dilatation of mammary ducts: feature analysis and BI-RADS assessment

Hsu, Hui‐Chi; Yu, Jyh Cherng; Hsu, Giu Cheng; Chang, Wen Han; Yu, Cheng; Tung, Ho-Jui; Tzao, Ching; Huang, Guo Shu

doi:10.1007/s00330-009-1546-8

Cited by 21 publications

(13 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…If US-guided large core needle biopsy has proven malignancy, one-step surgery without surgical biopsy could be possible. Advances in US technology have improved the ability not only to allow the detection of subtle changes attributable to an intraductal tumour itself (19,20), but also to identify and characterize clinically occult nonmass US findings (18,21,22). The US findings of NME lesions can be subtle or not apparent at all, and a careful scanning technique is needed for successful correlation between US and MRI.…”

Section: Discussionmentioning

confidence: 99%

Breast Nonmass Enhancement Detected with MRI: Uility and Lesion Characterization with Second-Look Ultrasonography

et al. 2015

Self Cite

View full text Add to dashboard Cite

The purpose of this study was to verify the utility of second-look ultrasonography (US) in evaluating nonmass enhancement (NME) lesions detected on breast magnetic resonance imaging (MRI) by analysing its correlation and imaging features. From July 2008 to June 2012, 102 consecutive MRI-detected NME lesions were subsequently evaluated with US. Lesions were evaluated according to the established Breast Imaging Reporting and Data System (BI-RADS) lexicon. The correlation between MRI-detected NME lesion characteristics, lesion size, histopathological findings and features at second-look US were analysed. Second-look US identified 44/102 (43%) of the NME lesions revealed by MRI. A US correlate was seen in 34/45 (76%) malignant lesions compared with 10/57 (18%) benign lesions (p < 0.0001). The likelihood of malignancy was significantly higher for NME lesions with a US correlate than lesions without: 34/44 (77%) versus 11/58 (19%) (p < 0.0001). The malignancy of the 44 (43%) MRI-detected NME lesions with a US correlate was significantly associated with US lesion margins and BI-RADS categories (p = 0.001 and 0.002 respectively). Second-look US of MRI-detected NME lesions is useful for decision-making as part of the diagnostic workup. Familiarity with the US features associated with malignancy improves the utility of US in the workup of these NME abnormalities.

show abstract

Section: Discussionmentioning

confidence: 99%

Breast Nonmass Enhancement Detected with MRI: Uility and Lesion Characterization with Second-Look Ultrasonography

et al. 2015

Self Cite

View full text Add to dashboard Cite

show abstract

“…The findings of multiplicity, lack of internal vascularity, and a mass without distortion of ductal contour favor a benign origin (37). Ductography is the mainstay of evaluation of ductal lesions when nipple discharge is present.…”

Section: Ductal Ectasiamentioning

confidence: 99%

“…However, a wide array of benign and malignant entities can manifest as dilated lactiferous ducts with or without an intraductal mass. These include fibrocystic change, intraductal papilloma, ductal hyperplasia, DCIS, and invasive ductal carcinoma (37).…”

Section: Ductal Ectasiamentioning

confidence: 99%

Echogenic Breast Masses at US: To Biopsy or Not to Biopsy?

Gao

Slanetz²,

Eisenberg³

2013

RadioGraphics

View full text Add to dashboard Cite

At ultrasonography (US), purely or predominantly echogenic breast masses are rare. These lesions were once assumed to be benign, but recent data suggest that approximately 0.5% of malignant breast lesions appear echogenic. However, correlation with the mammographic appearance, lesion location, and clinical history allows the need for biopsy to be determined. An echogenic mass that is radiolucent at mammography is benign. An echogenic mass that is not radiolucent at mammography may represent a hematoma, complex seroma, silicone granuloma, abscess, galactocele, or fat necrosis when the appropriate clinical history is present. In these cases, biopsy can usually be avoided. If there is a clinical history of cancer or radiation therapy, biopsy is often indicated to assess for metastasis or angiosarcoma. An echogenic mass in an ectatic duct warrants biopsy to exclude carcinoma. An echogenic skin lesion is most likely benign and can occasionally have peripheral vascularity due to surrounding inflammation. However, a skin lesion with internal vascularity is concerning for metastasis or lymphoma. If there is no suspicious clinical history, suspicious sonographic features or mammographic findings would lead to a recommendation for biopsy. Lesions with nonspecific imaging or clinical features (eg, angiolipoma or pseudoangiomatous stromal hyperplasia) may require biopsy to exclude malignancy.

show abstract

“…Sonografi eşliğinde yapı-lacak kesici iğne biyopsilerinde standart olarak 14G iğne kullanılsa da, küçük lezyonların ör-neklenmesinde ve 14G iğne ile penetrasyonun zorlanıldığı yoğun fibrokistik parankime sahip olgularda 16G iğneler de kullanılabilir. İntraduktal hipoekoik lezyonlar için biyopsi endikasyonu doğar [14]. Öncelikle debris ile mural solid lezyon ayrımı yapılmasına özen gösterilmelidir.…”

Section: Ultrasonografiunclassified

“…Doppler US ile vaskülarizasyonun gösterilmesi canlı hücre varlığını teyit edeceği gibi, gösterilememesi mural patolojiyi dışlamaz. Retroareolar bölge-den çok periferik yerleşimli, lobule konturlu, birden fazla duktus ile iştirakı bulunan lezyonlarda malignite olasılığı daha yüksektir [14].…”

Section: Ultrasonografiunclassified

Meme Biyopsisi: Hasta ve Yöntem Seçimi; Hangi Lezyonda Ne Yapalım?

Kılıç¹,

Yılmaz²

2014

Trd Sem

View full text Add to dashboard Cite

Ultrasonographic alterations associated with the dilatation of mammary ducts: feature analysis and BI-RADS assessment

Abstract: The four types of US classifications used in our study establish reliable references for the dilated duct patterns when stratified according to BI-RADS categories, and they clarify the indications for biopsy of these lesions.

Cited by 21 publications

References 25 publications

Breast Nonmass Enhancement Detected with MRI: Uility and Lesion Characterization with Second-Look Ultrasonography

Breast Nonmass Enhancement Detected with MRI: Uility and Lesion Characterization with Second-Look Ultrasonography

Echogenic Breast Masses at US: To Biopsy or Not to Biopsy?

Meme Biyopsisi: Hasta ve Yöntem Seçimi; Hangi Lezyonda Ne Yapalım?

Contact Info

Product

Resources

About